Search Within

Peter Illei

Formats
  1. Journal Article (15)
  2. Meeting Abstract (11)
Groups
  1. GSK Faculty (23)
  2. Tow Center for Developmental Oncology (TCDO) (23)
  3. Department of Pathology and Laboratory Medicine (21)
  4. Human Oncology and Pathogenesis Program (21)
  5. Surgery (12)
  6. Pediatrics, Department of (5)

More Groups

People
  1. Marc Ladanyi (21)
  2. Valerie Rusch (11)
  3. Maureen Zakowski (7)
  4. Zhiquan Zhao (5)
  5. Cristina Antonescu (4)
  6. Fernando Lopez-Rios (4)

More People

Years
  1. 2007 (1)
  2. 2006 (1)
  3. 2005 (1)
  4. 2004 (2)
  5. 2003 (8)
  6. 2002 (6)

More Years

Publications
  1. Laboratory Investigation (5)
  2. Modern Pathology (5)
  3. Cancer Research (3)
  4. American Journal of Pathology (2)
  5. Hepatology (2)
  6. Archives of Pathology & Laboratory Medicine (1)

More Publications

Publishers
  1. Nature Publishing Group (7)
  2. American Association for Cancer Research (5)
  3. Nature Research (5)
  4. Elsevier Science, Inc. (3)
  5. John Wiley & Sons (3)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma
    Journal Article

    Mora, J.; Lavarino, C.; Alaminos, M.; Cheung, N. K. V.; Rios, J.; de Torres, C.; Illei, P.; Juan, G.; Gerald, W. L.
    Genes Chromosomes and Cancer (2007)

    Fulltext@MSK | Save
  • Global gene expression profiling of pleural mesotheliomas: Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction
    Journal Article

    Lopez-Rios, F.; Chuai, S.; Flores, R.; Shimizu, S.; Ohno, T.; Wakahara, K.; Illei, P. B.; Hussain, S.; Krug, L.; Zakowski, M. F.; more...
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: A highly lethal subset associated with poor chemoresponse
    Journal Article

    Huang, H. Y.; Illei, P. B.; Zhao, Z.; Mazumdar, M.; Huvos, A. G.; Healey, J. H.; Wexler, L. H.; Gorlick, R.; Meyers, P.; Ladanyi, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids
    Journal Article

    Lopez-Rios, F.; Illei, P. B.; Rusch, V.; Ladanyi, M.
    Lancet (2004)

    Fulltext@MSK | Save
  • Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours
    Journal Article

    Mora, J.; Alaminos, M.; de Torres, C.; Illei, P.; Qin, J.; Cheung, N. K. V.; Gerald, W. L.
    British Journal of Cancer (2004)

    Fulltext@MSK | Save
  • The methylthioadenosine phosphorylase (MTAP) gene is homozygously co-deleted with CDKN2A in most mesotheliomas: Detection by fluorescent in situ hybridization (FISH) and by immunohistochemistry (IHC) using a novel MTAP monoclonal antibody
    Meeting Abstract

    Illei, P. B.; Leoni, L.; Huang, W.; Astrow, S.; Cheeks, A.; Rusch, V. W.; Ladanyi, M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • SV40 infection and p16/CDKN2A deletion as alternative mechanisms of p53 and RB pathway co-inactivation in a series of 65 mesotheliomas
    Meeting Abstract

    Lopez-Rios, F.; Illei, P. B.; Zhao, Z.; Rusch, V.; Zakowski, M. F.; Ladanyi, M.
    Modern Pathology (2003)

    Fulltext@MSK | Save
  • SV40 infection and p16/CDKN2A deletion as alternative mechanisms of p53 and RB pathway co-inactivation in a series of 65 mesotheliomas
    Meeting Abstract

    Lopez-Rios, F.; Illei, P. B.; Zhao, Z.; Rusch, V.; Zakowski, M. F.; Ladanyi, M.
    Laboratory Investigation (2003)

    Fulltext@MSK | Save
  • P53 mutation, P16/CDKN2A deletion, and EWS-FLI1 fusion type in Ewing sarcoma. An analysis of 60 cases
    Meeting Abstract

    Illei, P. B.; Zhao, Z.; Huang, H. Y.; Ladanyi, M.
    Modern Pathology (2003)

    Fulltext@MSK | Save
  • P53 mutation, P16/CDKN2A deletion, and EWS-FLI1 fusion type in Ewing sarcoma. An analysis of 60 cases
    Meeting Abstract

    Illei, P. B.; Zhao, Z.; Huang, H. Y.; Ladanyi, M.
    Laboratory Investigation (2003)

    Fulltext@MSK | Save